Cargando…
2346. Preliminary results of durable immune response induced by a self-amplifying mRNA (samRNA) SARS-CoV-2 vaccine candidate, GRT-R910, in adults previously vaccinated with mRNA or AZD1222 primary series
BACKGROUND: Neutralizing antibodies (nAbs) induced by authorized SARS-CoV-2 vaccines wane within months, requiring frequent boosters. Preliminary safety and immunogenicity of a samRNA-based SARS-CoV-2 vaccine candidate (GRT-R910) administered as a booster following AZD1222 primary series in older (≥...
Autores principales: | Uriel, Alison, Garbes, Pedro, Nagare, A, Kuan, J C, Palmer, Christine, Bae, K, Jooss, Karin, Rappaport, A, Kachura, Melissa, Kraemer, L, Venkatraman, Harshni, Jaroslavsky, Jason, Kounlavouth, Sonia, Marrali, M, Hart, Meghan, Betular, J, Allen, A, Green, C, Osanlou, O, Palfreeman, Adrian, Turgut, Tolga, Ustianowski, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677884/ http://dx.doi.org/10.1093/ofid/ofad500.1968 |
Ejemplares similares
-
2372. Preliminary evidence of durable immune responses induced by self-amplifying mRNA (samRNA) vaccine candidates against SARS-CoV-2 in vaccine-naive South African population
por: Koen, A, et al.
Publicado: (2023) -
GRT-R910: a self-amplifying mRNA SARS-CoV-2 vaccine boosts immunity for ≥6 months in previously-vaccinated older adults
por: Palmer, Christine D., et al.
Publicado: (2023) -
2395. An Interim Report of the Safety, Reactogenicity, and Immunogenicity of a Self-amplifying mRNA (samRNA) COVID-19 Vaccine GRT-R910 as a Booster in Healthy Adults
por: Whitaker, Jennifer, et al.
Publicado: (2023) -
mRNA as a Therapeutics: Understanding mRNA Vaccines
por: Oğuz, Ferdi, et al.
Publicado: (2022) -
mRNA Vaccine Platform: mRNA Production and Delivery
por: Litvinova, V. R., et al.
Publicado: (2023)